CASP9 rs1052571: What Your Genotype Means
The rs1052571 variant is a single nucleotide polymorphism located within the CASP9 gene. Research has investigated its potential role as a candidate marker for prostate cancer susceptibility and its influence on patient response to certain medical therapies.
What each genotype means
Increased cancer susceptibility marker
Research indicates that this genotype is associated with an increased risk of prostate cancer susceptibility in some populations. Additionally, this variant has been studied for its potential role in the response to anti-TNF therapy in Crohn's disease, though findings remain limited and require further validation. Please discuss any health concerns or clinical findings with your healthcare provider.
The frequency of this genotype varies significantly by ancestry and is generally less common than the homozygous G genotype in many global populations.
Increased cancer susceptibility marker
Studies have identified this genotype as a potential marker associated with an increased risk of prostate cancer susceptibility. Research also suggests this variant may influence how individuals with Crohn's disease respond to anti-TNF therapy, though the evidence is considered limited. You should consult with a clinician to discuss how these genetic findings relate to your personal health history.
This heterozygous genotype is found at varying frequencies across different global populations.
Baseline risk profile
This is the most common genotype for this variant in many populations. While some research has investigated this variant's role in prostate cancer susceptibility and response to certain therapies, the clinical significance for an individual with this genotype is not definitively established. Always consult with a medical professional regarding your health risks and any clinical decisions.
This is the ancestral and most frequently observed genotype in most global populations.
Understanding the rs1052571 Variant
The rs1052571 variant is a specific change in the DNA sequence of the CASP9 gene. In genetics, a single nucleotide polymorphism (SNP) like rs1052571 represents a variation at a single position in the genome. This particular variant is located within the CASP9 gene, which provides instructions for making the caspase-9 protein. Because this gene is involved in fundamental cellular processes, researchers often study how variations in its sequence might alter gene expression or protein function. While the variant is identified in scientific literature, it is important to note that the presence of a specific genotype does not determine a health outcome on its own. Genetic markers are often studied in the context of complex diseases where many factors, including environment and lifestyle, play significant roles in overall health.
The Role of the CASP9 Gene
The CASP9 gene encodes the caspase-9 protein, which is a critical component of the intrinsic apoptotic pathway. Apoptosis is a highly regulated process of programmed cell death that allows the body to eliminate damaged, aged, or unnecessary cells. Caspase-9 acts as an initiator caspase, meaning it triggers a cascade of events that leads to the orderly breakdown of a cell. Because this pathway is essential for maintaining tissue homeostasis and preventing the uncontrolled growth of cells, it is a frequent subject of cancer research. When the apoptotic machinery is impaired, cells that should have been removed may survive and proliferate, which is a hallmark of cancer development. Consequently, scientists investigate whether variants in genes like CASP9 might influence the efficiency of this process and, by extension, an individual's susceptibility to certain conditions.
Research Associations and Evidence Strength
Scientific studies have explored the association between rs1052571 and various health conditions, most notably prostate cancer. Meta-analyses have suggested that this variant may be linked to an increased risk of prostate cancer, though the evidence is considered limited and results can vary across different populations. Additionally, some research has examined whether this variant influences how patients with Crohn's disease respond to anti-TNF therapy. These studies suggest that the variant might be a candidate marker for treatment response, potentially affecting how the body reacts to biological medications. However, these findings are preliminary. Because these associations are based on statistical correlations in specific study groups, they do not establish a direct cause-and-effect relationship. Further large-scale, diverse population studies are necessary to confirm these findings and understand the underlying biological mechanisms.
Population Frequency
The frequency of the rs1052571 variant varies significantly across different global populations. Because genetic diversity is high, the prevalence of specific alleles can differ between ancestral groups, which is why researchers emphasize the need for diverse study cohorts. There is no single 'normal' frequency for this variant; rather, it exists at different rates depending on the population being studied. When interpreting genetic data, it is helpful to recognize that these frequency differences are a standard feature of human genetics and do not inherently imply a health risk or benefit.
What This Information Means for You
If you have information about your rs1052571 genotype, it is important to view it as a small piece of a much larger biological puzzle. Genetic associations with complex diseases like cancer are rarely definitive, and having a specific genotype does not mean you will develop a particular condition. This information is intended for educational purposes and should not be used for self-diagnosis or to make medical decisions. If you are concerned about your risk for prostate cancer or have questions about how your genetics might influence your response to medications, please consult with a qualified healthcare professional. They can provide context based on your personal and family medical history, which is far more predictive of health outcomes than any single genetic variant.
How common is this variant?
The frequency of the rs1052571 variant varies by ancestry, with different populations exhibiting distinct distributions of the C and T alleles.
Frequently asked questions
Is rs1052571 a diagnostic test for prostate cancer?
No, rs1052571 is not a diagnostic test. It is a genetic variant that has been studied for its statistical association with prostate cancer risk, but it cannot be used to diagnose the disease or predict an individual's health outcome.
Can I use this information to change my medication?
No. You should never change or stop any medication based on genetic information without first consulting your doctor or pharmacist. They are the only ones who can safely evaluate how your genetics might interact with your treatment plan.
Why do different studies show different results for this variant?
Genetic studies often show mixed results due to differences in study design, sample sizes, and the ancestral backgrounds of the participants. Additionally, complex diseases are influenced by many genes and environmental factors, which can mask the effect of a single variant.
Where can I find more information about my specific genetic results?
If you have received genetic testing results, the best resource is a genetic counselor or your primary care physician. They can help you interpret your report in the context of your overall health and family history.
Sources & further reading
Educational information only, last refreshed 10/30/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1052571?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29